{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:17:12Z","timestamp":1786119432333,"version":"build-2736575974"},"reference-count":21,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1097\/ftd.0b013e3181e649a0","type":"journal-article","created":{"date-parts":[[2010,7,12]],"date-time":"2010-07-12T06:34:17Z","timestamp":1278916457000},"page":"774-777","source":"Crossref","is-referenced-by-count":12,"title":["Interference Between Eplerenone and Digoxin in Fluorescence Polarization Immunoassay, Microparticle Enzyme Immunoassay, and Affinity Column-Mediated Immunoassay"],"prefix":"10.1097","volume":"32","author":[{"given":"Tomoyuki","family":"Yamada","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaoru","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken","family":"Iguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasutaka","family":"Kanada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryuji","family":"Kato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshio","family":"Ijiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masami","family":"Nishihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumiko","family":"Murakami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuya","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Tamai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiko","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-16-20210129","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1001\/jama.289.7.871","article-title":"Association of serum digoxin concentration and outcomes in patients with heart failure.","volume":"289","author":"Rathore","year":"2003","journal-title":"JAMA"},{"key":"R2-16-20210129","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1038\/287743a0","article-title":"Endogenous digitalis-like substances in plasma of volume-expanded dogs.","volume":"287","author":"Gruber","year":"1980","journal-title":"Nature"},{"key":"R3-16-20210129","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0009-9120(89)80064-5","article-title":"Digoxin-like immunoreactivity, displacement of ouabain and inhibition of Na+\/K+ATPase by four steroids known to be increased in essential hypertension.","volume":"22","author":"Seccombe","year":"1989","journal-title":"Clin Biochem"},{"key":"R4-16-20210129","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1161\/01.HYP.23.6.1027","article-title":"Role of brain ouabain like compound in central nervous system-mediated natriuresis in rat.","volume":"23","author":"Yamada","year":"1994","journal-title":"Hypertension"},{"key":"R5-16-20210129","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1093\/cvr\/25.5.371","article-title":"Endogenous plasma Na, K-ATPase inhibitory activity and digoxin like immunoreactivity after acute myocardial infarction.","volume":"25","author":"Bagrov","year":"1991","journal-title":"Cardiovasc Res"},{"key":"R6-16-20210129","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1161\/01.CIR.86.2.420","article-title":"Elevated concentrations of endogenous ouabain in patients with congestive heart failure.","volume":"86","author":"Gottlieb","year":"1992","journal-title":"Circulation"},{"key":"R7-16-20210129","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1053\/euhj.1999.1744","article-title":"Increased digitalis-like immunoreactive substances in patients with hypertrophic cardiomyopathy.","volume":"21","author":"Hayashi","year":"2000","journal-title":"Eur Heart J"},{"key":"R8-16-20210129","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-99-5-604","article-title":"An endogenous digoxin-like substance in patients with renal impairment.","volume":"99","author":"Graves","year":"1983","journal-title":"Ann Intern Med"},{"key":"R9-16-20210129","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1177\/106002808702100515","article-title":"Digoxin-like immunoreactive substances (DLIS) in liver disease: comparison of clinical and laboratory parameters in patients with and without DLIS.","volume":"21","author":"Gervais","year":"1987","journal-title":"Drug Intell Clin Pharm"},{"key":"R10-16-20210129","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1093\/clinchem\/33.8.1490a","article-title":"Endogenous digoxin-like immunoreactive substances eliminated from serum samples from patients with liver disease by the EMIT column digoxin assay.","volume":"33","author":"Kulaots","year":"1987","journal-title":"Clin Chem"},{"key":"R11-16-20210129","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1210\/jcem-58-4-748","article-title":"Endogenous digoxin-like immunoreactive substances in human pregnancies.","volume":"58","author":"Graves","year":"1984","journal-title":"J Clin Endocrin Metab"},{"key":"R12-16-20210129","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1097\/00007691-200304000-00015","article-title":"Digitalis-like immunoreactive substances in maternal and umbilical cord plasma; a comparative sensitivity study of fluorescence polarization immunoassay and microparticle enzyme immunoassay.","volume":"25","author":"Ijiri","year":"2003","journal-title":"Ther Drug Monit"},{"key":"R13-16-20210129","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1159\/000243114","article-title":"A study into the nature and organ source of digoxin-like immunoreactive substance(s) in the perinatal period.","volume":"56","author":"Seccombe","year":"1989","journal-title":"Biol Neonate"},{"key":"R14-16-20210129","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S0009-9120(05)80005-0","article-title":"Digoxin-like immunoreactivity in cord blood plasma extracts is not only due to endogenous corticosteroids.","volume":"24","author":"Yiannakou","year":"1991","journal-title":"Clin Biochem"},{"key":"R15-16-20210129","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1093\/clinchem\/29.11.1972","article-title":"Seven different digoxin immunoassay kits compared with respect to interference by a digoxin-like immunoreactive substances in serum from premature and full-term infants.","volume":"29","author":"Morris","year":"1983","journal-title":"Clin Chem"},{"key":"R16-16-20210129","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1097\/00007691-199806000-00018","article-title":"Comparison of microparticle enzyme and fluorescence polarization immunoassays in pediatric patients not receiving digoxin.","volume":"20","author":"Chicella","year":"1998","journal-title":"Ther Drug Monit"},{"key":"R17-16-20210129","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1111\/j.1365-2710.2004.00609.x","article-title":"Increased digitalis-like immunoreactive substances in neonatal plasma measured using fluorescence polarization immunoassay.","volume":"29","author":"Ijiri","year":"2004","journal-title":"J Clin Pharm Ther"},{"key":"R18-16-20210129","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1093\/clinchem\/43.8.1416","article-title":"Isolation and characterization of a digoxin-like immunoreactive substances from human urine by affinity chromatography.","volume":"43","author":"Angelis","year":"1997","journal-title":"Clin Chem"},{"key":"R19-16-20210129","first-page":"3","article-title":"Cross-reactivity between urobilinogen and digoxin; comparative sensitivity study of FPIA and MEIA. A relationship between urobilinogen and digitalis-like immunoreactive substances in human urine.","volume":"1","author":"Kato","year":"2008","journal-title":"Probl Ter Monit"},{"key":"R20-16-20210129","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1093\/clinchem\/48.3.507","article-title":"Digoxin assays: frequent, substantial, and potentially dangerous interference by spironolactone, canrenone, and other steroids.","volume":"48","author":"Steimer","year":"2002","journal-title":"Clin Chem"},{"key":"R21-16-20210129","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1177\/0091270005275894","article-title":"Pharmacokinetics of eplerenone after single and multiple dosing in subjects with and without renal impairment.","volume":"45","author":"Ravis","year":"2005","journal-title":"J Clin Pharmacol"}],"container-title":["Therapeutic Drug Monitoring"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/FTD.0b013e3181e649a0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:31:05Z","timestamp":1786041065000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00007691-201012000-00016"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12]]},"references-count":21,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/ftd.0b013e3181e649a0","relation":{},"ISSN":["0163-4356"],"issn-type":[{"value":"0163-4356","type":"print"}],"subject":[],"published":{"date-parts":[[2010,12]]}}}